معرفی
Dr. Gisli Einarsson is a Senior Research Fellow at the School of Pharmacy, Queen's University Belfast. His research focuses on respiratory microbiology, particularly cystic fibrosis (CF) and bronchiectasis, investigating the airway microbiota's role in disease progression and treatment responses. He has published extensively on topics such as microbial community dynamics, antibiotic resistance, and host-pathogen interactions.
- Education: Not explicitly stated in the text.
Research Interests include cystic fibrosis microbiology, microbial ecology of chronic lung diseases, and the impact of CFTR modulators on respiratory infections. His work contributes to UN Sustainable Development Goals related to health and well-being (SDG 3).
Recent articles analyze airway bacterial density in bronchiectasis, host innate immunity in CF exacerbations, and antibiotic prescribing practices for Pseudomonas aeruginosa infections. He has presented at international conferences on microbiome-driven treatments and CF management strategies.
Labs/Teams: Active collaborations in the CFMATTERS Consortium and ECFS-CTN network, focusing on microbiome profiling and clinical trial outcomes in CF.
